Unpacking the Impact of the Ozempic Economy on US Retail

The demand for GLP-1 drugs, specifically Ozempic, is on the rise in the pharmaceutical market due to their effectiveness in managing blood sugar levels and promoting weight loss. This trend reflects a growing focus on health and wellness among consumers.

The report highlights the impact of this widespread use of GLP-1 drugs on various sectors within the US retail market, including grocery and apparel. Companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart are mentioned as being affected by this trend.

Subscribers to the report can access exclusive insights into this topic by logging in to view the document. Those who are not subscribers can learn more about subscriptions and gain access to relevant research.